Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Breast Neoplasms 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Multimodal Imaging × Clear all
NCT03285841 2024-03-18

OCT-AF Imaging of Pre-cancers of Vulva and Cervix

British Columbia Cancer Agency

Terminated
20 enrolled
Gynecologic

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms, Vulvar Neoplasms

NCT00804544 2012-03-05

99mTc-MIBI SPECT/CT in Breast Malignancy

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase NA Terminated
4 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡